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Immune thymus-derived lymphocytes (T cells) generated during the course of virus 
infections of mice have,  m  most instances,  shown predictable specificity patterns  (1). 
Reciprocal exclusion of cytotoxic T-cell activity has been demonstrated for three diverse 
groups of viruses:  arenaviruses  [lymphocytic choriomeningitis virus  (LCMV)% poxvi- 
ruses (ectromelia and vaccinia), and paramyxoviruses (Sendai). The only aberrant find- 
ing  is  that  cytotoxic T  cells  from  mice  infected  with  LCMV  or  vaccinia  virus  lyse 
trinitrophenyl-modified lymphocytes (~2). 
Virus-immune T cells also exhibit another order of specificity, which could not have 
readily been foreseen. Effector T-cell function, as measured by both in vitro and in vivo 
criteria, is recognized only when virus-infected targets share H-2K or H-2D genes with 
the mouse strata in whmh the lymphocytes are sensitized (3-6). Such m the case for both 
the normal physiological situation, and for radiation chimeras in which H-2-different T 
cells apparently see alloantigen as self (7-10).  Either virus-immune T cells recognize both 
self (H-2) and nonself (virus), or the lymphocyte receptor is specffic for some neoantigen 
determined by both host and viral genomes (1'1, 12). 
Various speculations have been advanced to explain thin H-2 restriction phenomenon 
(7, 11, 12)  At one extreme is the idea that the T cell expresses two variable (V) genes, one 
specffic for self-H-2 and  the  other for virus  (12). The  most drastic  alternative  is the 
possibility that the infectious process results in derepression of cryptic host genes, and 
reactivity is directed solely against abnormally expressed alloantigens (13). This latter 
concept implies that the T cell does not recognize virus at all. It thus becomes important 
to  compare  T-cell  responses  resulting  from  exposure  to  different  viruses  of similar 
molecular bmlogy. 
The  influenza  viruses  offer an  ideal  experimental  system for this  purpose. 
Firstly, there is the possibility of using A  and B strain influenza viruses, which 
bear a  common host determinant  (if grown in chick embryo) but are otherwise 
serologically  distinct  (14).  Fine  specificity can  then  be  studied  within  the  A 
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strain viruses, which express different hemagglutinin (H) and neuraminidase 
surface antigens but share  internal  ribonucleoprotein  (RNP) and matrix  (M) 
components  (15).  We  have  thus  investigated T-cell  responses to  a  variety  of 
influenza  A  viruses,  representing  subtypes  first  isolated  from  man  in  1933 
(HON1), 1957 (H2N2), and 1968 (H3N2). 
Materials and Methods 
M~ce.  CBA/J, C57BL6/J (B6), C57BL/10 (B10), B10.A, B10.A(5R), B10.BR, and CBA/J × B6 FI 
mine were purchased from The Jackson Laboratory, Bar Harbor, Maine. B10.A(2R) and B10.A(4R) 
mine were bred in colomes maintained at the Wistar Institute by Dr. D  Gotze. 
V~ruses  The influenza A virus stratus PR6 [A/PR/8134 (HON1)],  Bel [A/Bellamy/42 (HON1)], 
AA [A/Ann Arbor/23/57 (H2N2)],  and NT60  [A/Northern Territory/60/68 (H2N2)] and the influ- 
enza B  strain  (BLee)  were omgmally obtained from Dr.  S.  Fazekas  de St.  Groth,  D~vlsion of 
Ammal Genetics, CSIRO,  Sydney, Austraha. The virus stratus Hick [A/Hlckox/40 (HON1)]  and 
HK/X31,  a  recombinant  between  PR8  and  a  Hong  Kong  strata  whmh  shows  the  antlgemc 
characteristms of the Hong Kong virus  (16)  were  supphed by the  Center for Disease  Control, 
Atlanta, Ga.  and Dr  R.  G.  Webster, St  Jude Childrens' Research Hospital,  Memphis, Tenn., 
respectively. Virus stocks of h~gh infectivity titer were grown m  the allanto~c cavity of embryo- 
nated chicken eggs, and stored frozen at -70°C. All such stocks contained between 1,200 and 3,000 
hemagglutinating (HA) U/ml (17). 
Immun~zatmn.  Mice were generally lmmumzed mtraperitoneally (1.p) with 1.0 ml of a  1.10 
dilution  (in phosphate-buffered saline)  of allantoic  fluid  containing wrus  (100-300  HA  U  per 
mouse)  In one expemment mice were anesthetized with chloroform, and given 50 ~tl of a  1:10,000 
dilution intranasally 
Cytotox~c T-Cell Assay.  The methods used are mmllar to those descmbed for other viruses (18). 
Briefly, L929 fibroblasts (L cells) were grown in RPMI 1640  (Flow Laboratories, Inc, Rockville, 
Md.) containing 10% fetal calf serum and antibiotics. This medmm was used throughout.  Cells 
were trypsinized,  pelleted,  washed,  and labeled for 1.5-2 h  at 37°C  with Na~lCr (New England 
Nuclear, Boston, Mass.) at a concentration of 250/~Cl/107 cells. The cells were then pelleted again 
and resuspended  m  medium  containing virus for  1 h  at  37°C,  washed  twine m  medium,  and 
dispensed into 96-hole plates (Lmbro Chemical Co., New Haven, Conn.) in 100 ~l of medmm to 
g~ve 1.5 ×  104 cells per well  The concentration used for the A strata viruses was 5.0 ml of a  1'10 
dflutmn of stock allantoic fluid in medium per 2 ×  107 cells (approximately 50 HA U per l0  s cells), 
while a  1:300 dilution (0.5 HA U  per l0  s cells) was used for the BLee. 
The target cells were then overlaid with the lymphocyte populations,  m  a  further 100  ~1 of 
medmm, and the assays were held overnight at 37°C m  a  humidified atmosphere containing 7% 
CO2 in air  Assay supernates (100  ~l) were then removed for 7-counting. The initial assays were 
incubated for 16 h, but background levels of 51Cr release were found to be rather high (from 30 to 
40%)  All experiments are now done using a  12 h  assay which gives a  background, for normal 
spleen cells or medium, ranging from 20 to 30% of hydrolysis. The water lysls value is determined 
by  adding  100  ~1  (1.5  ×  104  cells)  of the  target  cell  population  to  1.9  ml  of distilled  water, 
incubating this with the assay, and then measuring the number of counts present m  1.0 ml of the 
supernate 
All results are expressed as mean percent specific ~Cr release for rephcates of three or four 
wells. Standard errors within the groups were reproducibly less than 5%, and generally below 2%, 
and  are  not shown for clarity  of presentation of results  The formula  (1)  used for calculating 
percent specific 51Cr release is (It-Nt)  ×  100/Wt-Nt, where W is water lysis, t  is the target, I  is 
immune lymphocytes, and N is normal lymphocytes. Uninfected L cells were carried as controls m 
many experiments, but were not killed by immune spleen cells. 
Lymphocytes  Immune spleen and lymph node cell populations were processed and depleted of 
erythrocytes as described prevmusly (1)  Vmbility was determined by trypan blue exclusion, and 
all ratios quoted in the results are adjusted to vmble cell counts. Some lymphocyte preparatmns 
were depleted of B cells by passage through nylon wool columns (19), and T cells were removed by 
incubation with a rabbit anti-mouse brain serum [anti-T, (20)] and guinea pig complement  This 
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Radmimmunoassay.  Unlabeled, virus-infected L cells were prepared and plated into wells as 
described for the cytotoxic assay. After overnight incubation they were fixed with 0.15% glutaral- 
dehyde and were used as immunoadsorbents in a radioimmunoassay (RIA) as described by Segal 
and Klinman (21). This involved incubation of the immunoadsorbent with an appropriate dilution 
of mouse serum, followed by quantitation of the bound mouse Ig by means of ~I-labeled rabbit- 
anti-mouse antibody 
Results 
Specificity Between  Type A  and B  Influenza  Viruses and  Vaccinia.  Mice 
were immunized  i.p.  with large doses of influenza virus and spleen cells were 
assayed for effector function on virus-infected L cells. Maximal cytotoxic activity 
was observed at 5 days after exposure to PR8 (HON1) or BLee, and the response 
was specific for the  immunizing  virus  (Table I).  Reciprocal  exclusion of lytic 
function was also observed for PR8 and vaccinia virus (Table II). The specificity 
demonstrated is thus of the same order as found previously for other viruses (1). 
Cross-Reactivity Between Type A  Viruses.  Reciprocal priming with different 
strains  of influenza  A  viruses revealed a  pattern  of complete cross-reactivity 
(Table III). The different viruses varied in their immunogenic capacity: effector 
lymphocytes from mice given  PR8,  HKX31,  and  NT60  were the  most active. 
However, all populations were lytic for the HONI-, H2N2-, and H3N2-infected 
target  cells.  No clear  indication  was found of preference  for the  homologous 
interaction. 
This  result  was  somewhat  surprising  as  Cambridge  et  al.  (23)  had  found 
previously that cytotoxic lymph node cells from mice infected with influenza A 
viruses show specificity for the virus H  antigen.  Differences from the present 
study are that the effectors were not identified as T cells and that only one strain 
(A/WSN, HON1) was used for immunization and tested on targets infected with 
a  variety of viruses.  Another possible source of discrepancy is that virus given 
i.p.  in  large  quantities  may  be  processed  in  an  unphysiological  way,  with 
resultant generation of aberrant T-cell specificities. Cytotoxic assays were thus 
made using mediastinal  lymph node cells from mice infected intranasally  with 
much  lower doses of virus.  Again  the  same specificity pattern  was observed, 
with complete cross-reactivity between the type A viruses, but reciprocal exclu- 
sion of cytotoxicity for BLee (Table IV). 
All viruses used in the present study were grown in the allantoic cavity of the 
chick  embryo.  Virus  particles  produced  in  this  way are  known  to  express  a 
chicken  host  component  (14),  which  is  common to  influenza  A  and  B  strain 
viruses and normal allantoic fluid. Both the reciprocal exclusion of cytotoxicity 
for influenza A and B viruses and the fact that mice immunized with allantoic 
fluid did not generate effector capacity for either influenza virus-infected targets 
or for L  cells previously incubated  with the  normal  allantoic  fluid  (Table V) 
indicates  that  the cross-reactivity observed for A  strain  viruses is not due to 
immunization  with a  common antigen of chicken origin. 
Also, serum antibodies detected in mice immunized by the procedure used to 
generate  cytotoxic spleen  cells  did  not  show any  significant  cross-reactivity. 
Significant binding of antibody was recognized only for target cells infected with 
the virus  used for immunization  (Table VI).  Apparently  the virus-infected  L 
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TABLE  I 
Specificity of Cell-Mediated LyE,s for Influenza A and B V~ruses 
% 51Cr release from virus-infected L cells 
Immune*  Days after moc-  PR8  BLee 
spleen  ulation 
50:1  100'1  50 1  100:1 
PR8 
BLee 
3  3  15  4  0 
5  48  64  4  9 
7  25  28  5  5 
3  0  0  25  36 
5  0  2  32  49 
7  11  7  20  18 
* B10,BR mice were inoculated i.p. with a  1:10 dilution of allantoic fired contammg 
influenza virus  Assays were incubated for 16 h  at 37°C 
TABLE  II 
Reciprocal Exclusmn of Cytototoxic~ty for Influenza and Vacc~nm 
V~ruses 
% slCr release from L cells 
Immune spleen*  PR8  Vaccmla 
25:1  50-1  25.1  50.1 
PR8  32  40  0  3 
Vaccima  0  0  79  96 
* CBA/J mice were immunized 1.p. 5 days previously with 250 HA umts of PR8 
influenza virus, or intravenously with l0  s TCID~0 of vaccmia virus (22). The 
vaccmia-immune populahon was enriched for T  cells by passage through 
nylon wool (19)  The assays were incubated for 12 h  at 37°C 
TABLE  III 
Extenswe Cross-Reactw~ty Between Spleen Cell Populatmns  from M~ce Immunized 
w~th Different A Strain Viruses 
Immune spleen* 
% ~'Cr release from virus-infected L cells 
PR8 HON1  Bel HON1  AA H2N2  NT60 H2N2  HK H3N2 
PR8  70  78  31  48  60 
Be1  19  16  22  12  28 
Hmk  38  18  25  16  32 
AA  50  33  36  38  51 
NT60  58  42  36  46  62 
HK  62  41  41  46  50 
* CBA/J.mme were immunized 1.p. 5 days previously. The results given are for a ratio of 50 spleen 
cells:l  target cell  Data for  Hmk  (HON1)  targets is not shown,  as background levels of ~lCr 
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TABLE IV 
Cytotoxic Actiwty of Medlastinal Lymph Node Cells from Mwe with Influenza 
Pneumonm 
% Specific 5~Cr release 
Mediastmal*  PR8 (HONI)  HKX3  (H3N2)  BLee  lymph node 
25:1  50:1  25:1  50:1  25:1  50:1 
PR8  30  51  26  42  0  0 
HKX31  20  31  22  31  0  0 
BLee  5  3  0  0  41  74 
* Mice  were dosed  mtranasally 7 days previously with 50  /zl of a  10 -4 dilution of stock wrus. 
Pneumonia was most severe in those given PRS, and least marked m mice dosed with HKX31. 
TABLE V 
Cross-Reactw~ty Does Not Reflect Immuntzation  with Egg Antigens 
Immune population* 
% 5~Cr release from L cells 
Allantoic fluid  PR8 HON1  HKX31 H3N2  BLee 
Allantmc flmd  0  0  1  0 
PR8  0  54  72  4 
HKX31  0  50  71  6 
BLee  0  0  8  27 
* CBA/J ×  B6 F~ mice were injected 1 p.  with influenza virus or a comparable (1:10) dilution of 
normal allantmc fluid  Assays (100:1) were incubated for 12 h at 37°C. 
TABLE  VI 
Lack of Serological Cross-Reactwity between Influenza A and B V~ruses 
Immunizing* virus  Day of samphng 
ftg of antibody per ml of serum binding to:$ 
L-PR8  L-HK  L-BLee 
PR8 (HON1)  14  235  7  3 
HK (H3N2)  13  8  65  4 
PR8 (HON1)  23  300  4  4 
HK (H3N2)  23  9  240  4 
BLee  23  5  5  205 
Normal serum  4  2  4 
* CBA/J mice were lmmumzed by the procedure used to generate cytotoxlc T cells. 
Virus-infected L-cell monolayers were prepared by the technique used for the cytotoxic T-cell 
assay, incubated for 16 h at 37°C, and fixed with 0.15% glutaraldehyde for RIA (21). 
(HON1) and HKX31 (H3N2) viruses which is readily demonstrable by serological 
techniques. 
Identity of the Cytotoxic Population.  What is the nature of the effector cell in 
influenza-immune  spleen?  Cytotoxic  activity  was  considerably  enhanced  by 
passing  lymphocytes through  nylon  wool columns  (Table  VH),  which  tend  to 
remove antibody-forming cell precursors (B cells) and enrich for T cells (19).  The 
same cross-reactivity pattern was observed for the purified populations. Effector 
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TABLE  VII 
Effect of Nylon Wool Depletion and Treatment with Anti-T Serum 
and Complement 
Spleen* population 
PR8 (HONI)  AA (H2N2) 
12 h  16 h  12 h  16 h 
PR8 immune  39  49  13  36 
Nylon wool effluent  74  98  34  52 
Nylon wool adherent  35  38  14  33 
Ant~-T +  C  0  0  0  3 
Complement alone  49'  60  9  49 
Washed$  45  68  16  46 
AA immune  30  48  11  32 
Nylon wool effluent  60  81  39  63 
Nylon wood adherent  17  35  10  39 
Anti-T + C  0  0  0  0 
Complement alone  33  46  22  45 
Washed$  41  60  22  48 
* CBA/J x  B6 F, mice were dosed 1.p. 5 days previously. Immune populations 
were assayed at 100:1, after passage through nylon wool columns (19) or 
treatment with antl-T serum and complement (20). Approximately 30% of 
spleen cells were recovered after either treatment 
$ Processed in parallel with the two preceding groups. 
TABLE  VIII 
Immune Lys~s is Maximal When Target and T  Cell Share H-2 Genes* 
Mouse strain 
H-2 type 
I 
K ABC SD 
% 5'Cr release from HK-mfected L cells (H-2  ~  ) 
25:1  50" 1  100:1 
B10  bbbbbb  6  4  5 
B10 A  kkkddd  16  18  18 
B10.A(2R)  kkkddb  16  19  20 
B10.A(4R)  kkbbbb  13  17  21 
B10 A(5R)  bbbddd  0  1  1 
B10.Br  kkkkkk  21  28  38 
B6  bbbbbb  0  0  0 
CBA/J  kkkkkk  22  23  33 
CBA/J x B6 F,  21  27  42 
* Mice were immumzed i.p. with HKX31 virus and killed 5 days later 
guinea pig complement.  Also, specific lysis was mediated only by virus-immune 
spleen cells which share H-2K  ~ or H-2D  ~ genes with the virus-infected L  cells 
(Table VIII), a  constraint  that  is unique  for T  cells (7). It thus seems apparent 
that  the effectors operating in these assays are cytotoxic T  cells. This confirms 
earlier findings of Yap and Ada (24) for the A/WSN  strain of influenza virus. 
Evidence for Different T-Cell Subsets.  Subdivision of cytotoxic T-cell speci- 
ficities with respect to requirement  for H-2K or H-2D  compatibility is readily 
achieved  by  utilizing  "cold-target"  competitive-inhibition  protocols  (25).  The 
same  is true  for  differentiating  between  the  effects  of priming  with  different 
viruses (Fig. 1). Cross-reactive cytotoxic T-cell activity recognized for the heter- 
ologous interaction  (e.g., HON1 --* H3N2) is abrogated to the same extent when R.  B.  EFFROS,  P.  C.  DOHERTY,  W.  GERHARD,  AND  J.  BENNINK  563 
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FIG.  1  Inhlbztlon of zmmune spleen cell effectors (100:1)  in a  12 h  assay using dzfferent 
ratios of cold, unlabeled competitor cells. The competitors were normal L cells (N), or L cells 
infected with BLee, PR8 (HON1), or HKX31 (H3N2) 4 h  before the 5~Cr-labeled targets were 
infected with one of these stratus of influenza virus 
either  HON1 or  H3N2 virus-infected,  unlabeled  cells  are  interposed  between 
lymphocyte and target. Little inhibition is recognized when normal L cells, or L 
cells infected with BLee are used as competitors.  In the homologous situation 
(e.g., HON1 --* HON1), however, much greater inhibition is recognized with the 
HON1 competitor than with the H3N2-infected cells. The converse is also true. 
Apparently at least two populations of immune T cells are functioning, the one 
being cross-reactive between different A strain viruses, the other specific for the 
homologous virus.  This is the first time that  we have been able to subdivide 
virus-immune T-cell specificities, other than on the basis of requirement for H-2 
compatibility. 
Cross-Priming.  Further  evidence for cross-reactivity between PR8 (HON1) 
and  HKX31  (H3N2)  influenza  virus-immune  T  cells  was  found  when  mice 
primed with PR8 were challenged 3 wk later with HKX31. A second exposure to 
PR8 resulted in cytotoxic activity less than that observed for primary immuniza- 
tion (Fig. 2). This reduction probably reflects neutralization of the input virus by 
antibody.  Memory PR8 mice challenged  with HKX31,  however, generate  im- 
mune  spleen  cells  which  are  more  lytic for both the  HON1 and  H3N2 virus- 
infected target cells. Is cross-priming of T cells central to the "original antigenic 564  SPECIFICITY  OF  INFLUENZA-IMMUNE  T  CELLS 
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Fro.  2.  CBA/J mice were rejected Lp. with a  1:10 dilution of allantoic fluid containing PR8 
(HON1) influenza virus. These mice were then challenged (secondary) i.p. 21 days later with 
the same dose of PR8 or HKX31 (H3N2) influenza virus, and spleen cells were assayed after 
a  further 5 days. Previously unexposed mice were immunized at the same time (primary). 
The assays were incubated for 12 h  at 37°C. Specific ~lCr release caused by memory spleen 
cells  from  unchallenged  PR8  memory  mice  was  <5%,  as  were  cytotoxic  activities  of all 
spleen populations for normal  L cells. 
sin"  phenomenon?  Current  experiments  are  concerned  with  analyzing  this 
question. 
Discussion 
Recognition  that  there  is  extensive  cross-reactivity  in  the  cytotoxic  T-cell 
response to different influenza type A  viruses raises important questions con- 
cerning  the role  of cell-mediated  immunity  (CMI)  in influenza.  Studies  with 
ectromelia and LCMV indicate that cytotoxic, or surveillance (26), T cells are of 
prime importance in elimination of virus-infected cells in vivo (4-7). Capacity to 
adoptively transfer effector function in these two diseases correlates closely with 
cytotoxic activity measured in vivo, and is subject to the same requirement for 
H-2K  or H-2D  identity  between  stimulator  environment  and  virus-infected 
target cell,  or recipient  mouse. 
Is  this  also  true  for  influenza?  If so,  the  fact  that  widespread  exposure  of 
human populations to one A  strain influenza virus apparently does not protect 
against a  new,  serologically  distinct pandemic strain  (27) might be thought to 
mean that CMI plays no significant role in this disease. There is, however, some 
experimental  evidence that mice previously infected with an HON1  virus sup- R.  B.  EFFROS,  P.  C.  DOHERTY,  W.  GERHARD,  AND  J.  BENNINK  565 
port decreased virus replication on subsequent challenge with an H2N2 strain 
(28). Other studies indicate that T cells may, as in LCMV (7), mediate immuno- 
pathological process (29,  30).  Perhaps human influenza reflects both protective 
and immunopathological consequences ofT-cell effector function. May this have 
been a  factor in the extremely high mortality observed in young adults during 
the 1918 pandemic? Availability of an in vitro correlate for CMI should consider- 
ably facilitate an experimental  approach to such questions (7,  18). 
What are the cross-reactive T cells recognizing? One possibility is that the T- 
cell receptor is specific for an "altered self' determinant,  perhaps an abnormally 
expressed alloantigen  (13), which is common to cells infected with very similar 
viruses.  An alternative  is that  shared virus components,  such as the internal 
RNP and M protein, may be expressed in some way on the surface of the virus- 
infected cell. This is, however, thought not to occur (15). Even so, the M protein 
aligns on the cytoplasmic face of the plasma membrane  (15).  Could this induce 
some specific complementary modification,  or rearrangement  of molecules, on 
the outside of the lipid-protein bilayer? Such a change would not be detected by 
antisera directed against M protein purified from egg-grown virus (15). 
Another consideration is that this is a  rather acute immune response, being 
maximal at 5 days after primary immunization.  Perhaps the specificity of the T- 
cell receptor is equivalent  to that  of an  early IgM,  which  may be much  less 
restricted than the late IgG used to serologically define influenza strains  (14). 
The same mechanism  [anti-idiotype response? (31)] that regulates IgM produc- 
tion may also prevent further clonal expansion of effector T cells. 
The fact that virus-specific T-cell populations can also be demonstrated indi- 
cates that  at  least part  of the  T-cell  repertoire  is directed against  the  virus. 
Perhaps we are considering a continuum of recognition. We know that a single 
mouse produces more than one B-cell clone specific for a  given H  antigen  (32). 
The same V gene products may als0 be expressed on T cells (33, 34). The binding 
characteristics,  and thus the specificity, of a secreted Ig molecule may be quite 
different from that of multiple recognition structures  [single Ig heavy chains? 
(33, 34)] arranged in a  stable matrix,  such as the cell membrane  (12).  Some T- 
cell clones may thus be highly cross-reactive,  even though free Ig is not,  the 
degree of specificity depending  (as always) on the uniqueness of the antigenic 
site recognized. 
The  central  question  is  whether  we  can  account  for this  T-cell  specificity 
pattern in terms of known components of influenza virus. This may be possible. 
A range of recombinant viruses are available (14),  monoclonal antisera can be 
generated (32), and the various virus proteins can be obtained in pure form (15). 
Is there any need to invoke an "altered self' concept, other than at the level of 
associative recognition of virus and H-2 antigen? 
Summary 
Specificity of cytotoxic T-cell function was investigated for a range of different 
influenza  viruses.  T  cells from mice immunized  with A  or B  strain  influenza 
viruses,  or  with  vaccinia  virus,  showed  reciprocal  exclusion  of cytotoxicity. 
Extensive cross-reactivity was, however, found for lymphocyte populations from 
mice infected with a variety of serologically distinct influenza A viruses, though 566  SPECIFICITY  OF  INFLUENZA-IMMUNE  T  CELLS 
serum antibodies did not cross-react when tested in a  radioimmunoassay using 
comparable  target  cells  as  immunoadsorbents.  This  apparent  lack  of T-cell 
specificity was recognized for immune spleen cells generated after intraperito- 
neal inoculation of high titers of virus, and for mediastinal lymph node popula- 
tions  from mice with  pneumonia  due  to  infection  with  much  less  virus.  The 
phenomenon could not be explained on the basis of exposure to the chicken host 
component, which is common to A  and B strain viruses. However, not all of the 
virus-immune  T-cell  clones  are  cross-reactive.  Competitive-inhibition  experi- 
ments  indicate  that  a  considerable  proportion  of the  lymphocyte response  is 
restricted  to  the  immunizing  virus.  Even  so,  the  less  specific  component  is 
significant.  Also,  exposure  to  one  type  A  virus  was  found  to  prime  for  an 
enhanced cell-mediated immunity response after challenge with a  second, sero- 
logically different A  strain virus. 
We thank Dr  D. Gotze for supplying both recombinant mouse strains and the antl-T serum; Dr 
W. E. B~ddison for advice concerning nylon wool columns; and Marge Solomon, Maureen Carey, 
and Mmhael Mehno for capable techmcal assistance 
Recewed for publication 3 November 1976. 
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